CERULLO, VINCENZO
CERULLO, VINCENZO
Dipartimento di Medicina molecolare e Biotecnologie mediche
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model
2022 Vitale, M.; Scialo, F.; Passariello, M.; Leggiero, E.; D'Agostino, A.; Tripodi, L.; Gentile, L.; Bianco, A.; Castaldo, G.; Cerullo, V.; De Lorenzo, C.; Pastore, L.
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
2021 Ylosmaki, E.; Ylosmaki, L.; Fusciello, M.; Martins, B.; Ahokas, P.; Cojoc, H.; Uoti, A.; Feola, S.; Kreutzman, A.; Ranki, T.; Karbach, J.; Viitala, T.; Priha, P.; Jager, E.; Pesonen, S.; Cerullo, V.
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
2021 Hamdan, F.; Ylosmaki, E.; Chiaro, J.; Giannoula, Y.; Long, M.; Fusciello, M.; Feola, S.; Martins, B.; Feodoroff, M.; Antignani, G.; Russo, S.; Kari, O.; Lee, M.; Jarvinen, P.; Nisen, H.; Kreutzman, A.; Leusen, J.; Mustjoki, S.; Mcwilliams, T. G.; Gronholm, M.; Cerullo, V.
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
2021 Hamdan, F.; Martins, B.; Feodoroff, M.; Giannoula, Y.; Feola, S.; Fusciello, M.; Chiaro, J.; Antignani, G.; Gronholm, M.; Ylosmaki, E.; Cerullo, V.
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
2021 Ylosmaki, E.; Fusciello, M.; Martins, B.; Feola, S.; Hamdan, F.; Chiaro, J.; Ylosmaki, L.; Vaughan, M. J.; Viitala, T.; Kulkarni, P. S.; Cerullo, V.
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma
2021 Chiaro, J.; Kasanen, H. H. E.; Whalley, T.; Capasso, C.; Gronholm, M.; Feola, S.; Peltonen, K.; Hamdan, F.; Hernberg, M.; Makela, S.; Karhapaa, H.; Brown, P. E.; Martins, B.; Fusciello, M.; Ylosmaki, E. O.; Greco, D.; Kreutzman, A. S.; Mustjoki, S.; Szomolay, B.; Cerullo, V.
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy
2021 Peltonen, K.; Feola, S.; Umer, H. M.; Chiaro, J.; Mermelekas, G.; Ylosmaki, E.; Pesonen, S.; Branca, R. M. M.; Lehtio, J.; Cerullo, V.
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification
2021 Feola, S.; Haapala, M.; Peltonen, K.; Capasso, C.; Martins, B.; Antignani, G.; Federico, A.; Pietiainen, V.; Chiaro, J.; Feodoroff, M.; Russo, S.; Rannikko, A.; Fusciello, M.; Koskela, S.; Partanen, J.; Hamdan, F.; Tahka, S. M.; Ylosmaki, E.; Greco, D.; Gronholm, M.; Kekarainen, T.; Eshaghi, M.; Gurvich, O. L.; Yla-Herttuala, S.; M. Branca R., M.; Lehtio, J.; Sikanen, T. M.; Cerullo, V.
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
2022 Feola, Sara; Chiaro, Jacopo; Martins, Beatriz; Russo, Salvatore; Fusciello, Manlio; Ylösmäki, Erkko; Bonini, Chiara; Ruggiero, Eliana; Hamdan, Firas; Feodoroff, Michaela; Antignani, Gabriella; Viitala, Tapani; Pesonen, Sari; Grönholm, Mikaela; Branca, Rui M M; Lehtiö, Janne; Cerullo, Vincenzo
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes
2021 Tripodi, L.; Passariello, M.; D'Argenio, V.; Leggiero, E.; Vitale, M.; Colicchio, R.; Salvatore, P.; Cerullo, V.; De Lorenzo, C.; Pastore, L.
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
2020 Torrieri, G.; Fontana, F.; Figueiredo, P.; Liu, Z.; Ferreira, M. P. A.; Talman, V.; Martins, J. P.; Fusciello, M.; Moslova, K.; Teesalu, T.; Cerullo, V.; Hirvonen, J.; Ruskoaho, H.; Balasubramanian, V.; Santos, H. A.
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site
2019 Lopes, A.; Feola, S.; Ligot, S.; Fusciello, M.; Vandermeulen, G.; Preat, V.; Cerullo, V.
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy
2019 Ylosmaki, L.; Polini, B.; Carpi, S.; Martins, B.; Smertina, E.; Feola, S.; Fusciello, M.; Peltonen, K.; Nieri, P.; Ylosmaki, E.; Cerullo, V.
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach
2020 Vitale, A.; Capasso, C.; Leggiero, E.; Garofalo, M.; Kuryk, L.; Hirvinen, M.; D'Alessio, F.; Perrotta, C.; Verdesca, F.; Ranieri, A.; Salvatore, F.; Pastore, L.; Buono, P.; Cerullo, V.; Lombardo, B.
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
2020 Saari, H.; Turunen, T.; Lohmus, A.; Turunen, M.; Jalasvuori, M.; Butcher, S. J.; Yla-Herttuala, S.; Viitala, T.; Cerullo, V.; Siljander, P. R. M.; Yliperttula, M.
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma
2020 Polini, B.; Carpi, S.; Doccini, S.; Citi, V.; Martelli, A.; Feola, S.; Santorelli, F. M.; Cerullo, V.; Romanini, A.; Nieri, P.
Design and application of oncolytic viruses for cancer immunotherapy
2020 Ylosmaki, E.; Cerullo, V.
Uncovering the tumor antigen landscape: What to know about the discovery process
2020 Feola, S.; Chiaro, J.; Martins, B.; Cerullo, V.
Pathogens: Our Allies against Cancer?
2021 Buonaguro, L.; Cerullo, V.
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
2019 Fontana, F.; Fusciello, M.; Groeneveldt, C.; Capasso, C.; Chiaro, J.; Feola, S.; Liu, Z.; Makila, E. M.; Salonen, J. J.; Hirvonen, J. T.; Cerullo, V.; Santos, H. A.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model | 1.1 Articolo in rivista | 2022 | Vitale, M.; Scialo, F.; Passariello, M.; Leggiero, E.; D'Agostino, A.; Tripodi, L.; Gentile, L.; Bianco, A.; Castaldo, G.; Cerullo, V.; De Lorenzo, C.; Pastore, L. | |
| Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform | 1.1 Articolo in rivista | 2021 | Ylosmaki, E.; Ylosmaki, L.; Fusciello, M.; Martins, B.; Ahokas, P.; Cojoc, H.; Uoti, A.; Feola, S.; Kreutzman, A.; Ranki, T.; Karbach, J.; Viitala, T.; Priha, P.; Jager, E.; Pesonen, S.; Cerullo, V. | |
| Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids | 1.1 Articolo in rivista | 2021 | Hamdan, F.; Ylosmaki, E.; Chiaro, J.; Giannoula, Y.; Long, M.; Fusciello, M.; Feola, S.; Martins, B.; Feodoroff, M.; Antignani, G.; Russo, S.; Kari, O.; Lee, M.; Jarvinen, P.; Nisen, H.; Kreutzman, A.; Leusen, J.; Mustjoki, S.; Mcwilliams, T. G.; Gronholm, M.; Cerullo, V. | |
| GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses | 1.1 Articolo in rivista | 2021 | Hamdan, F.; Martins, B.; Feodoroff, M.; Giannoula, Y.; Feola, S.; Fusciello, M.; Chiaro, J.; Antignani, G.; Gronholm, M.; Ylosmaki, E.; Cerullo, V. | |
| Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin | 1.1 Articolo in rivista | 2021 | Ylosmaki, E.; Fusciello, M.; Martins, B.; Feola, S.; Hamdan, F.; Chiaro, J.; Ylosmaki, L.; Vaughan, M. J.; Viitala, T.; Kulkarni, P. S.; Cerullo, V. | |
| Viral molecular mimicry influences the antitumor immune response in murine and human melanoma | 1.1 Articolo in rivista | 2021 | Chiaro, J.; Kasanen, H. H. E.; Whalley, T.; Capasso, C.; Gronholm, M.; Feola, S.; Peltonen, K.; Hamdan, F.; Hernberg, M.; Makela, S.; Karhapaa, H.; Brown, P. E.; Martins, B.; Fusciello, M.; Ylosmaki, E. O.; Greco, D.; Kreutzman, A. S.; Mustjoki, S.; Szomolay, B.; Cerullo, V. | |
| Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy | 1.1 Articolo in rivista | 2021 | Peltonen, K.; Feola, S.; Umer, H. M.; Chiaro, J.; Mermelekas, G.; Ylosmaki, E.; Pesonen, S.; Branca, R. M. M.; Lehtio, J.; Cerullo, V. | |
| PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification | 1.1 Articolo in rivista | 2021 | Feola, S.; Haapala, M.; Peltonen, K.; Capasso, C.; Martins, B.; Antignani, G.; Federico, A.; Pietiainen, V.; Chiaro, J.; Feodoroff, M.; Russo, S.; Rannikko, A.; Fusciello, M.; Koskela, S.; Partanen, J.; Hamdan, F.; Tahka, S. M.; Ylosmaki, E.; Greco, D.; Gronholm, M.; Kekarainen, T.; Eshaghi, M.; Gurvich, O. L.; Yla-Herttuala, S.; M. Branca R., M.; Lehtio, J.; Sikanen, T. M.; Cerullo, V. | |
| A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines | 1.1 Articolo in rivista | 2022 | Feola, Sara; Chiaro, Jacopo; Martins, Beatriz; Russo, Salvatore; Fusciello, Manlio; Ylösmäki, Erkko; Bonini, Chiara; Ruggiero, Eliana; Hamdan, Firas; Feodoroff, Michaela; Antignani, Gabriella; Viitala, Tapani; Pesonen, Sari; Grönholm, Mikaela; Branca, Rui M M; Lehtiö, Janne; Cerullo, Vincenzo | |
| Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes | 1.1 Articolo in rivista | 2021 | Tripodi, L.; Passariello, M.; D'Argenio, V.; Leggiero, E.; Vitale, M.; Colicchio, R.; Salvatore, P.; Cerullo, V.; De Lorenzo, C.; Pastore, L. | |
| Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction | 1.1 Articolo in rivista | 2020 | Torrieri, G.; Fontana, F.; Figueiredo, P.; Liu, Z.; Ferreira, M. P. A.; Talman, V.; Martins, J. P.; Fusciello, M.; Moslova, K.; Teesalu, T.; Cerullo, V.; Hirvonen, J.; Ruskoaho, H.; Balasubramanian, V.; Santos, H. A. | |
| Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site | 1.1 Articolo in rivista | 2019 | Lopes, A.; Feola, S.; Ligot, S.; Fusciello, M.; Vandermeulen, G.; Preat, V.; Cerullo, V. | |
| Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy | 1.1 Articolo in rivista | 2019 | Ylosmaki, L.; Polini, B.; Carpi, S.; Martins, B.; Smertina, E.; Feola, S.; Fusciello, M.; Peltonen, K.; Nieri, P.; Ylosmaki, E.; Cerullo, V. | |
| Application of array-comparative genomic hybridization analysis in immune-virotherapy approach | 1.1 Articolo in rivista | 2020 | Vitale, A.; Capasso, C.; Leggiero, E.; Garofalo, M.; Kuryk, L.; Hirvinen, M.; D'Alessio, F.; Perrotta, C.; Verdesca, F.; Ranieri, A.; Salvatore, F.; Pastore, L.; Buono, P.; Cerullo, V.; Lombardo, B. | |
| Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery | 1.1 Articolo in rivista | 2020 | Saari, H.; Turunen, T.; Lohmus, A.; Turunen, M.; Jalasvuori, M.; Butcher, S. J.; Yla-Herttuala, S.; Viitala, T.; Cerullo, V.; Siljander, P. R. M.; Yliperttula, M. | |
| Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma | 1.1 Articolo in rivista | 2020 | Polini, B.; Carpi, S.; Doccini, S.; Citi, V.; Martelli, A.; Feola, S.; Santorelli, F. M.; Cerullo, V.; Romanini, A.; Nieri, P. | |
| Design and application of oncolytic viruses for cancer immunotherapy | 1.1 Articolo in rivista | 2020 | Ylosmaki, E.; Cerullo, V. | |
| Uncovering the tumor antigen landscape: What to know about the discovery process | 1.1 Articolo in rivista | 2020 | Feola, S.; Chiaro, J.; Martins, B.; Cerullo, V. | |
| Pathogens: Our Allies against Cancer? | 1.1 Articolo in rivista | 2021 | Buonaguro, L.; Cerullo, V. | |
| Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor | 1.1 Articolo in rivista | 2019 | Fontana, F.; Fusciello, M.; Groeneveldt, C.; Capasso, C.; Chiaro, J.; Feola, S.; Liu, Z.; Makila, E. M.; Salonen, J. J.; Hirvonen, J. T.; Cerullo, V.; Santos, H. A. |